Manipal Health Enterprises authorizes KMPs to decide materiality

2 min read     Updated on 05 Aug 2026, 10:08 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Manipal Health Enterprises Limited has empowered its Key Managerial Personnel, including MD Dilip Jose and CFO Sameer Agarwal, to determine the materiality of events for regulatory disclosures. This authorization under SEBI Listing Regulations aims to streamline compliance and ensure timely investor communication. The details were filed with BSE and NSE on August 5, 2026.

powered bylight_fuzz_icon
47493485

*this image is generated using AI for illustrative purposes only.

The Board of Directors of manipal health enterprises limited has authorized its Key Managerial Personnel (KMPs) to determine the materiality of events or information and make the requisite disclosures to stock exchanges. This decision streamlines the company's compliance process under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. By delegating this authority, the company ensures timely dissemination of material information to investors while adhering to regulatory frameworks.

This authorization applies to four senior executives who will now jointly assess whether specific events or information meet the threshold for public disclosure. The move aligns with the company’s Policy on Determination of Materiality of Events or Information. The intimation was submitted to BSE Limited and the National Stock Exchange of India Limited on August 5, 2026.

Authorized Key Managerial Personnel

The following executives have been granted the authority to determine materiality:

Name Designation Contact Details
Dilip Jose Managing Director and Chief Executive Officer Mobile: +91 80493 60300; E-mail: legalcs@maipalhospitals.com
Sameer Agarwal Chief Financial Officer Not disclosed
Karthik Rajagopal Chief Operating Officer Not disclosed
Sathish K R Company Secretary and Compliance Officer Not disclosed

Dilip Jose serves as the Managing Director and Chief Executive Officer, providing strategic oversight for these determinations. Sameer Agarwal acts as the Chief Financial Officer, bringing financial expertise to the assessment of materiality. Karthik Rajagopal, the Chief Operating Officer, contributes operational insights. Sathish K R, the Company Secretary and Compliance Officer, ensures that all disclosures comply with regulatory requirements.

Regulatory Context

Regulation 30 of the SEBI Listing Regulations mandates listed entities to promptly disclose any price-sensitive information to stock exchanges. Paragraph 5 of Regulation 30 allows companies to delegate the determination of materiality to their Board or a committee thereof, or to Key Managerial Personnel. Manipal Health Enterprises Limited has chosen the latter approach, empowering its top management to act swiftly in identifying and disclosing material events.

The details of these authorized personnel are available on the company’s website for transparency. This structure aims to enhance the efficiency of corporate communications and ensure that stakeholders receive accurate and timely information regarding significant developments affecting the company.

What the Numbers Show

While this filing does not contain financial metrics, the delegation of materiality determination reflects a governance choice to centralize disclosure decisions within the executive team. This can lead to faster response times to emerging events compared to requiring full Board approval for each assessment. The inclusion of both operational (Karthik Rajagopal) and financial (Sameer Agarwal) leaders alongside the CEO suggests a holistic approach to evaluating what constitutes material information for investors.

Historical Stock Returns for Manipal Health Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
-0.66%+14.15%+14.15%+14.15%+14.15%+14.15%

How might this delegation of authority impact the speed and frequency of material disclosures compared to previous Board-level assessments?

What specific operational or financial thresholds have been defined in the company's policy to guide these four executives in determining materiality?

Could this centralized decision-making structure increase the risk of selective disclosure or conflicts of interest among the Key Managerial Personnel?

Manipal Health Enterprises
View Company Insights
View All News
like18
dislike

Manipal Health confirms KFin as Registrar and Share Transfer Agent

1 min read     Updated on 05 Aug 2026, 02:22 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Manipal Health Enterprises Limited appointed KFin Technologies Limited as its Registrar and Share Transfer Agent effective February 13, 2025. The move complies with SEBI LODR Regulation 7(1). The filing was submitted on August 5, 2026.

powered bylight_fuzz_icon
47465520

*this image is generated using AI for illustrative purposes only.

Manipal Health Enterprises Limited has confirmed the appointment of KFin Technologies Limited as its Registrar and Share Transfer Agent (R&SA). The appointment, effective from February 13, 2025, ensures compliance with Regulation 7(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This structural update standardizes share transfer processes for investors.

The company disclosed this appointment in a filing dated August 5, 2026, submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE). The disclosure was made under Regulation 7(1) of the SEBI LODR Regulations, 2015, which mandates timely intimation of changes in R&SA appointments to ensure transparency and operational continuity for shareholders.

KFin Technologies Limited, headquartered at 301, The Centrium, 3rd Floor, 57, Lal Bahadur Shastri Road, Nav Pada, Kurla (West), Mumbai, Maharashtra, India, 400 070, continues to act in this capacity. The firm handles critical investor services including share transfers, transmission of shares, and maintenance of the register of members.

The filing was signed by Sathish K R, Company Secretary and Compliance Officer of Manipal Health Enterprises Limited, bearing Membership No. A15203. The digital signature timestamp indicates the submission occurred on August 5, 2026, at 11:31:54 IST.

Key Details

Parameter Detail
Appointed R&SA KFin Technologies Limited
Effective Date February 13, 2025
Regulatory Basis SEBI LODR Regulation 7(1), 2015
Filing Date August 5, 2026
Authorized Signatory Sathish K R (Company Secretary)

This appointment aligns with standard corporate governance practices for listed entities in India, ensuring that shareholder records are maintained by a specialized agency approved by regulatory standards.

Historical Stock Returns for Manipal Health Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
-0.66%+14.15%+14.15%+14.15%+14.15%+14.15%

How might the six-month delay between the effective date and the public filing impact investor confidence in Manipal Health's corporate governance transparency?

What operational efficiencies or cost savings does Manipal Health Enterprises expect to realize by standardizing share transfer processes through KFin Technologies?

Are there any pending shareholder disputes or transmission issues that this R&SA appointment aims to resolve or streamline?

Manipal Health Enterprises
View Company Insights
View All News
like19
dislike

More News on Manipal Health Enterprises Limited

Must Read Next

Earnings

MMP Industries Q1 Results: PBT doubles YoY to 162M, Revenue up to 2.3B 2 mins ago
no imag found
Astra Microwave Q1 Results: Net Profit Down to ₹123M, Revenue Falls YoY 2 mins ago

Corporate Actions

CESC Expands Renewable Portfolio with 1.4 GW Acquisition via Purvah Green Power for INR 4,859 Crores 12 mins ago

Stocks

M&B Engineering Approves Heavy Structural Steel Expansion, Adding 10,000 MTPA Capacity at Sanand Plant 7 mins ago
no imag found
MICL Group Gets Approval for High-End Sea-View Project Worth Over ₹1000 Crore Near Bandstand, Bandra West, Mumbai 13 mins ago
1 Year Returns:+14.15%